Proven pulmonary cryptococcosis due to capsule-deficient Cryptococcus neoformans does not differ clinically from proven pulmonary cryptococcosis due to capsule-intact Cr. neoformans

Mycoses

Volumn 48, Issue 1, 2005, Pages 21-24

  Torres, H A ^a   Prieto, V G ^a   Raad, I I ^a   Kontoyiannis, Dimitrios P ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Capsule deficiency; Cryptococcosis; Cryptococcus neoformans; Pneumonia

Indexed keywords

ANTIFUNGAL AGENT; FUNGUS ANTIGEN; STEROID;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; CANCER CHEMOTHERAPY; CAPSULE DEFICIENCY; CAPSULE DEFICIENT CRYPTOCOCCUS NEOFORMANS; CAPSULE INTACT CRYPTOCOCCUS NEOFORMANS; CLINICAL ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; FUNGAL VIRULENCE; FUNGUS CULTURE; HUMAN; HUMAN TISSUE; LEUKEMIA; LYMPHOCYTOPENIA; LYMPHOMA; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; SEROLOGY; SOLID TUMOR; STEROID THERAPY; THORAX RADIOGRAPHY; TREATMENT OUTCOME;

ADULT; AGED; ANTIGENS, FUNGAL; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; HUMANS; LUNG; LUNG DISEASES, FUNGAL; MIDDLE AGED; POLYSACCHARIDES;

FILOBASIDIELLA NEOFORMANS; FUNGI;

EID: 13844280534     PISSN: 09337407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1439-0507.2004.01068.x     Document Type: Article

References (11)

1. Mitchell TG, Perfect JR. Cryptococcosis in the era of AIDS - 100-years after the discovery of Cryptococcus neoformans. Clin Microbiol Rev 1995; 8: 515-48.
2. Fromtling RA, Shadomy HJ, Jacobson ES. Decreased virulence in stable, acapsular mutants of Cryptococcus neoformans. Mycopathologia 1982; 79: 23-9.
3. Kimura M, Kaufman L, Maekura S, Teramura K, Satou T, Hashimoto S. Pulmonary cryptococcosis due to a capsule-deficient strain confused with metastatic lung cancer. Mycopathologia 1997-98; 140: 65-8.
4. Harding SA, Scheid WM, Feldman PS, Sande MA. Pulmonary infection with capsule-deficient Cryptococcus neoformans. Virchows Arch A Pathol Anat Histol 1979; 382: 113-8.
5. Ro JY, Lee SS, Ayala AG. Advantage of Fontana-Masson stain in capsule-deficient cryptococcal infection. Arch Pathol Lab Med 1987; 111: 53-7.
6. Farmer SG, Komorowski RA. Histologic response to capsule-deficient Cryptococcus neoformans. Arch Pathol 1973; 96: 383-7.
7. Ascioglu S, Rex JH, de Pauw B et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002; 34: 7-14.
8. Kucsera J, Yarita K, Takeo K et al. Infra-strain variability of Cryptococcus neoformans can be detected on phloxin B medium. J Basic Microbiol 2002; 42; 111-9.
9. Doering TL. How does Cryptococcus get its coat? Trends Microbiol 2000; 8: 547-53.
10. Levitz SM, DiBenedetto DJ. Paradoxical role of capsule in murine bronchoalveolar macrophage-mediated killing of Cryptococcus neoformans. J Immunol 1989; 142: 659-65.
11. Perfect JR. Fungal virulence genes as targets for antifungal chemotherapy. Antimicrob Agents Chemother 1996; 40: 1577-83.